PMID: 375342Apr 23, 1979Paper

The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man

Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
I HillebrandP Berchtold

Abstract

In blind studies the effects of a new alpha-glucosidase inhibitor (BAY g 5421) were tested in normal weight and overweight male volunteers after oral application of 75, 150, or 300 mg of BAY g 5421 or placebo per os before three standardized main meals of one day. Before and three hours after each meal blood glucose, serum insulin, and serum triglyceride levels were determined. In addition, safety studies were performed. BAY g 5421 induced a statistically significant, in part dose-dependent inhibition of the postprandial increase of blood glucose- and serum insulin levels. The reduction of the postprandial increase of serum triglyceride levels was variable. Routine blood chemistry and hematology tests have revealed no adverse side effects; but the application of the drug was frequently associated with intestinal effects, such as flatulence and diarrhea, which were substrate (carbohydrate) and, in part, dose-dependent.

References

Oct 1, 1977·Die Naturwissenschaften·D D SchmidtD Schäfer
Sep 15, 1965·Klinische Wochenschrift·F MelaniE F Pfeiffer
Dec 1, 1974·American Heart Journal·A M Roberts
Dec 20, 1969·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·A R Walker

❮ Previous
Next ❯

Citations

Apr 23, 1979·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·I HillebrandP Berchtold
Jul 1, 1983·Pharmacology, Biochemistry, and Behavior·Z Glick, G A Bray
Aug 1, 1986·Pharmacology, Biochemistry, and Behavior·Z GlickU Sod-Moriah
May 1, 1995·Diabetes Research and Clinical Practice·Y GotoH Ikeda
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·N HottaH Kakuta
Jun 9, 1998·Physiology & Behavior·B E WrightM J Katovich
Aug 1, 1997·Diabetes Research and Clinical Practice·K NodaH Nawata
Jun 16, 1999·Diabetes Research and Clinical Practice·R ScottT Welborn
Nov 7, 1998·Diabetes & Metabolism·A J Scheen
Aug 1, 1987·Clinical and Experimental Pharmacology & Physiology·F P KennedyJ E Gerich
Oct 11, 2007·Diabetes, Obesity & Metabolism·O SchnellUNKNOWN Acarbose-Insulin Combination Study Group
Mar 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·N HottaN Sakamoto
May 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·N HottaN Sakamoto
Dec 6, 2000·The Journal of Small Animal Practice·R W Nelson
Jun 30, 2011·Nutrition & Metabolism·H Mohamed Sham ShihabudeenKavitha Thirumurugan
Sep 2, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Shinobu TanakaHiromichi Okuda
Apr 18, 2000·Journal of the American Veterinary Medical Association·R W NelsonC Briggs
Jul 1, 1997·Clinical Therapeutics·S KageyamaS Nakano
May 18, 2004·Journal of Diabetes and Its Complications·Kenji WatanabeRyuzo Kawamori
May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·G RiccardiC Bianchi
Jan 26, 1999·Journal of Gastroenterology and Hepatology·T HasegawaI Makino
Aug 1, 1981·British Journal of Obstetrics and Gynaecology·P T TownsendW P Collins
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Aug 24, 1999·Annals of Internal Medicine·R A DeFronzo
Jan 1, 1986·Journal of the American College of Nutrition·P A Crapo
May 9, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Maya MuramatsuHiroshi Hara
Mar 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·I Hillebrand
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·T William-Olsson
Jan 1, 1981·The Diabetes Educator·P A Crapo
Jul 1, 1998·Journal of Diabetes and Its Complications·M Hanefeld
May 1, 1984·Biochemical Pharmacology·N HaugaardG Wildey
Jun 8, 2021·Frontiers in Bioengineering and Biotechnology·Chun-Yue WengYu-Guo Zheng
May 1, 1990·Diabetes Research and Clinical Practice·Y OkabayashiM Otsuki
Nov 25, 2004·Best Practice & Research. Clinical Gastroenterology·L Van GaalH J Verkade

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
I HillebrandP Berchtold
Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
W F Caspary, S Graf
Clinica Chimica Acta; International Journal of Clinical Chemistry
I SuehiroS Baba
© 2021 Meta ULC. All rights reserved